Protara Therapeutics, Inc. (TARA) Earnings History
Net Loss14 years of earnings data (2012–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Protara Therapeutics, Inc. (TARA) Earnings Overview
As of July 8, 2026, Protara Therapeutics, Inc. (TARA) reported trailing twelve-month net income of -$63M, reflecting +38.2% year-over-year growth. The company earned $-1.48 per diluted share over the past four quarters.
Looking at the long-term picture, TARA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3M in fiscal 2014.
Protara Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RCKT (-$209M net income), FOLD (-$27M net income, -4.3% margin), RARE (-$609M net income, -85.4% margin), TARA has comparable earnings metrics. Compare TARA vs RCKT →
TARA Earnings vs Peers
Earnings metrics vs comparable public companies
TARA Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$57M | -28.8% | -$65M | $-1.34 | - | - |
| 2024 | -$45M | -10.3% | -$49M | $-2.17 | - | - |
| 2023 | -$40M | +38.7% | -$44M | $-3.57 | - | - |
| 2022 | -$66M | -39.6% | -$67M | $-5.86 | - | - |
| 2021 | -$47M | -39.1% | -$47M | $-4.20 | - | - |
| 2020 | -$34M | -126.6% | -$34M | $-4.70 | - | - |
| 2019 | -$15M | +41.1% | -$15M | $-3.63 | - | - |
| 2018 | -$25M | +15.1% | -$26M | $-9.93 | - | - |
| 2017 | -$30M | -5.0% | -$30M | $-69.38 | - | - |
| 2016 | -$29M | -33.4% | -$29M | $-68.90 | - | - |
| 2015 | -$21M | -539.6% | -$21M | $-51.94 | - | - |
| 2014 | -$3M | +57.8% | -$8M | $-10.24 | -113.4% | -257.1% |
| 2013 | -$8M | +0.7% | -$7M | $-37.43 | - | - |
| 2012 | -$8M | - | -$8M | $-37.62 | - | - |
Download Data
Export TARA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TARA — Frequently Asked Questions
Quick answers to the most common questions about buying TARA stock.
What is TARA earnings per share (EPS)?
TARA trailing twelve-month (TTM) diluted EPS is $-1.48, reflecting +38.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is Protara Therapeutics, Inc.'s net income?
Protara Therapeutics, Inc. (TARA) trailing twelve-month net income is $-63M as of 2025. Earnings grew +38.2% year-over-year.
Is TARA profitable?
TARA is not currently profitable on a TTM basis, reporting a net loss of $-63M. Net margin is N/A. Investors should monitor for a return to profitability.
What is TARA's earnings growth rate?
TARA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are TARA's profit margins?
Protara Therapeutics, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -31.6%.
Is TARA growing earnings?
Yes, TARA earnings are accelerating — EPS growth of +38.2% exceeds the 5-year CAGR of N/A. TTM net income reached $-63M. Earnings momentum is strengthening.
What was TARA's best earnings year?
Protara Therapeutics, Inc.'s highest annual net income on record is $-3M, achieved in fiscal year 2014. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were TARA's earnings last quarter?
TARA's most recent reported quarter was Q1 2026. Net income was $-18M with diluted EPS of $-0.42. For a full breakdown of all quarters, see the quarterly earnings table on this page.